Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Nilotinib | 19.9526 | uM | 4 | 1250.00 | 814.29 | 1470.00 | 1590.00 | 0.9245 | 0.8439 |
| SK-BR-3 | Nilotinib | 0.1 | uM | 4 | 1250.00 | 814.29 | 1697.00 | 1590.00 | 1.0673 | 1.1396 |
| SK-BR-3 | PLX-4720 | 0.1 | uM | 4 | 1250.00 | 814.29 | 1799.00 | 1590.00 | 1.1314 | 1.2729 |
| SK-BR-3 | PLX-4720 | 1 | uM | 4 | 1250.00 | 814.29 | 1764.00 | 1590.00 | 1.1094 | 1.2271 |
| SK-BR-3 | NVP-TAE684 | 0.1 | uM | 4 | 1250.00 | 814.29 | 1728.00 | 1590.00 | 1.0868 | 1.1801 |
| SK-BR-3 | Nilotinib | 10 | uM | 4 | 1250.00 | 814.29 | 1006.00 | 1590.00 | 0.6327 | 0.2448 |
| SK-BR-3 | Nilotinib | 0.01 | uM | 4 | 1250.00 | 814.29 | 1661.00 | 1590.00 | 1.0447 | 1.0926 |
| SK-BR-3 | Etoposide | 19.9526 | uM | 4 | 1250.00 | 814.29 | 623.00 | 1590.00 | 0.3918 | -0.2422 |
| SK-BR-3 | 0 | uM | 4 | 1250.00 | 814.29 | 1753.00 | 1590.00 | 1.1025 | 1.2128 | |
| SK-BR-3 | 0 | uM | 4 | 1250.00 | 814.29 | 1174.00 | 1590.00 | 0.7384 | 0.4608 | |
| SK-BR-3 | 0 | uM | 4 | 1250.00 | 814.29 | 1513.00 | 1590.00 | 0.9516 | 0.8998 | |
| SK-BR-3 | 0 | uM | 4 | 1250.00 | 814.29 | 1546.00 | 1590.00 | 0.9723 | 0.9427 | |
| SK-BR-3 | Etoposide | 1 | uM | 4 | 1250.00 | 814.29 | 730.00 | 1590.00 | 0.4591 | -0.1070 |
| SK-BR-3 | NVP-TAE684 | 0.0016596 | uM | 4 | 1250.00 | 814.29 | 1456.00 | 1590.00 | 0.9157 | 0.8257 |
| SK-BR-3 | 0 | uM | 4 | 1250.00 | 814.29 | 1739.00 | 1590.00 | 1.0937 | 1.1945 | |
| SK-BR-3 | NVP-TAE684 | 10 | uM | 4 | 1250.00 | 814.29 | 612.00 | 1590.00 | 0.3849 | -0.2561 |
| SK-BR-3 | Nilotinib | 0.0033113 | uM | 4 | 1250.00 | 814.29 | 1702.00 | 1590.00 | 1.0704 | 1.1461 |
| SK-BR-3 | NVP-TAE684 | 0.0033113 | uM | 4 | 1250.00 | 814.29 | 1839.00 | 1590.00 | 1.1566 | 1.3253 |
| SK-BR-3 | Nilotinib | 0.31623 | uM | 4 | 1250.00 | 814.29 | 1650.00 | 1590.00 | 1.0377 | 1.0782 |
| SK-BR-3 | PLX-4720 | 3.1623 | uM | 4 | 1250.00 | 814.29 | 1784.00 | 1590.00 | 1.1220 | 1.2533 |
| SK-BR-3 | NVP-TAE684 | 1 | uM | 4 | 1250.00 | 814.29 | 1751.00 | 1590.00 | 1.1013 | 1.2101 |
| SK-BR-3 | Etoposide | 0.1 | uM | 4 | 1250.00 | 814.29 | 1536.00 | 1590.00 | 0.9660 | 0.9297 |
| SK-BR-3 | Nilotinib | 0.031623 | uM | 4 | 1250.00 | 814.29 | 2058.00 | 1590.00 | 1.2943 | 1.6127 |
| SK-BR-3 | 0 | uM | 4 | 1250.00 | 814.29 | 1503.00 | 1590.00 | 0.9453 | 0.8868 | |
| SK-BR-3 | PLX-4720 | 19.9526 | uM | 4 | 1250.00 | 814.29 | 1417.00 | 1590.00 | 0.8912 | 0.7751 |